# Intracochlear Dexamethasone Application During Cochlear Implantation for Preserving Cochlear Cells

> **NCT04397354** · NA · COMPLETED · sponsor: **Pamukkale University** · enrollment: 34 (actual)

## Conditions studied

- Hearing Loss, Sensorineural

## Interventions

- **DRUG:** Intracochlear Dexamethasone
- **DRUG:** Intratympanic Dexamethasone
- **DRUG:** No additional drugs(control Group)

## Key facts

- **NCT ID:** NCT04397354
- **Lead sponsor:** Pamukkale University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-03-02
- **Primary completion:** 2022-08-01
- **Final completion:** 2022-09-20
- **Target enrollment:** 34 (ACTUAL)
- **Last updated:** 2023-01-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04397354

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04397354, "Intracochlear Dexamethasone Application During Cochlear Implantation for Preserving Cochlear Cells". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04397354. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*